Excedrin
NDC Package 0067-2045-83

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Excedrin is a . Marketed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc, this product is identified by NDC 0067-2045 and is authorized under FDA application part343.

Identification & Billing

NDC Package Code
0067-2045-83
Package Description
1 BOTTLE in 1 CARTON / 125 TABLET, FILM COATED in 1 BOTTLE
Product Code
0067-2045
11-Digit Billing Format
00067204583
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Excedrin Tension Headache
Dosage Form
-

Regulatory & Marketing

Labeler Name
Glaxosmithkline Consumer Healthcare Holdings (us) Llc
FDA Application #
part343
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
10-31-2005
End Marketing Date
12-31-2014
Listing Expiration
12-31-2014
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0067-2045). Click a package code to view its specific billing and regulatory data.

0067-2045-02
2 TABLET, FILM COATED in 1 POUCH
0067-2045-07
250 TABLET, FILM COATED in 1 BOTTLE
0067-2045-24
1 BOTTLE in 1 CARTON / 24 TABLET, FILM COATED in 1 BOTTLE
0067-2045-50
1 BOTTLE in 1 CARTON / 50 TABLET, FILM COATED in 1 BOTTLE
0067-2045-77
1 BOTTLE in 1 CARTON / 250 TABLET, FILM COATED in 1 BOTTLE
0067-2045-84
125 TABLET, FILM COATED in 1 BOTTLE
0067-2045-91
1 BOTTLE in 1 CARTON / 100 TABLET, FILM COATED in 1 BOTTLE
0067-2045-94
100 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0067-2045-83 identifies a specific commercial package of 1 bottle in 1 carton / 125 tablet, film coated in 1 bottle of Excedrin Tension Headache, labeled by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Glaxosmithkline Consumer Healthcare Holdings (us) Llc on October 31, 2005. The current certification is valid through December 31, 2014.

How is this Glaxosmithkline Consumer Healthcare Holdings (us) Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00067204583. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0067-2045-83
11-Digit CMS (5-4-2)
00067-2045-83

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.